Abstract:This figure presents a worldwide vision illustrating the relationship between the frequencies of HLA‐C04 and HLA‐A02 alleles and their respective associations with COVID‐19 susceptibility and mortality rates across different regions. The darker shaded areas represent regions with moderate‐to‐high frequencies of selected alleles and higher rates of susceptibility and mortality from COVID‐19. However, there are exceptions, such as China, where despite a higher frequency of HLA‐C04, lower incidence and mortality rates are observed. This suggests the influence of factors beyond host genetics, including government policies (e.g., Zero‐COVID‐19 policy), timely implementation of quarantine measures, access to vaccines and treatments, and well‐equipped medical facilities. Similarly, the figure highlights the protective effect of HLA‐A02 allele, which is associated with lower COVID‐19 susceptibility and reduced mortality rates. However, variations in this protective effect are observed, possibly due to the aforementioned contributing factors. Background The COVID‐19 pandemic has had a profound global impact, with variations in susceptibility, severity, and mortality rates across different regions. While many factors can contribute to the spread and impact of the disease, specifically human leukocyte antigen (HLA) genetic variants have emerged as potential contributors to COVID‐19 outcomes. Methods In this comprehensive narrative review, we conducted a thorough literature search to identify relevant studies investigating the association between HLA genetic variants and COVID‐19 outcomes. Additionally, we analyzed allelic frequency data from diverse populations to assess differences in COVID‐19 incidence and severity. Results Our review provides insights into the immunological mechanisms involving HLA‐mediated responses to COVID‐19 and highlights potential research directions and therapeutic interventions. We found evidence suggesting that certain HLA alleles, such as HLA‐A02, may confer a lower risk of COVID‐19, while others, like HLA‐C04, may increase the risk of severe symptoms and mortality. Furthermore, our analysis of allele frequency distributions revealed significant variations among different populations. Conclusion Considering host genetic variations, particularly HLA genetic variants, is crucial for understanding COVID‐19 susceptibility and severity. These findings have implications for personalized treatment and interventions based on an individual's genetic profile. However, further research is needed to unravel the precise mechanisms underlying the observed associations and explore the potential for targeted therapies or preventive measures based on HLA genetic variants.

Variation within the non-coding genome influences genetic and epigenetic regulation of the human leukocyte antigen genes

Single Nucleotide Polymorphisms in the Regulatory Regions of the HLA-DRB-expressed Genes

Epigenetic Regulation of Differential Hla-A Allelic Expression Levels

MHC Locus Variation

The influence of HLA genetic variation on plasma protein expression

Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for Hla Class I Genes

Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens

The role of HLA genetic variants in COVID‐19 susceptibility, severity, and mortality: A global review

Extensive Variation in Chromatin States Across Humans

Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?

Exploring the genetic basis of human population differences in DNA methylation and their causal impact on immune gene regulation

Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells

Adaptive immune receptor germline gene variation

SLE Non-Coding Genetic Risk Variant Determines the Epigenetic Dysfunction of an Immune Cell Specific Enhancer That Controls Disease-Critical Microrna Expression

Human Leukocyte Antigen Class I and II Alleles in Non-Hodgkin Lymphoma Etiology

Differential modulation of mutant CALR and JAK2 V617F-driven oncogenesis by HLA genotype in myeloproliferative neoplasms

A High-Resolution HLA and SNP Haplotype Map for Disease Association Studies in the Extended Human MHC.

Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes

Unveiling the Significance of HLA and KIR Diversity in Underrepresented Populations

Correlating Sequence Variation with HLA‐A Allelic Families: Implications for T Cell Receptor Binding Specificities